Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells (Q39422677)

11 September 2017

Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells (English)

1 reference

Sebastian Wachsmann-Hogiu

11 September 2017

1 reference

6

object named as

Sebastian Wachsmann-Hogiu

1 reference

11 September 2017

Hongyong Zhang

1

1 reference

11 September 2017

Juntao Luo

2

1 reference

11 September 2017

Yuanpei Li

3

1 reference

11 September 2017

Paul T Henderson

4

1 reference

11 September 2017

Yanchun Wang

5

1 reference

11 September 2017

Weixin Zhao

7

1 reference

11 September 2017

Kit S Lam

8

1 reference

11 September 2017

Chong-xian Pan

9

1 reference

11 September 2017

23 December 2011

1 reference

Nanomedicine: Nanotechnology, Biology and Medicine

11 September 2017

1 reference

11 September 2017

8

1 reference

11 September 2017

7

1 reference

11 September 2017

1116-1124

1 reference

Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

Anthracycline dose intensification in acute myeloid leukemia

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

High-dose daunorubicin in older patients with acute myeloid leukemia

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

Targeting the leukemic stem cell: the Holy Grail of leukemia therapy

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

Implications of cancer stem cells in the treatment of cancer

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

Characterization of clonogenic multiple myeloma cells

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

The "One-Bead-One-Compound" Combinatorial Library Method

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

Therapeutic options for acute myelogenous leukemia

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

A new type of synthetic peptide library for identifying ligand-binding activity

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4577023

Rituximab treatment provides no clinical benefit in patients with pretreated advanced multiple myeloma

21 August 2018

1 reference

12 December 2020

Variant diphtheria toxin-interleukin-3 fusion proteins with increased receptor affinity have enhanced cytotoxicity against acute myeloid leukemia progenitors

1 reference

12 December 2020

Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides

1 reference

12 December 2020

A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors

1 reference

12 December 2020

Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture

1 reference

12 December 2020

10.1016/J.NANO.2011.12.004

Identifiers

DOI

1 reference

11 September 2017

1 reference

11 September 2017

PubMed publication ID

22197725

1 reference